11h
Hosted on MSNTalazoparib-Enzalutamide Improves Survival in Metastatic CRPCAdding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...
The American Cancer Society estimates for cancer of the uterus in the United States for 2025 are: About 69,120 new cases of cancer of the uterus will be diagnosed. About 13,860 women will die from ...
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...
The FY2024 revenue forecast remains unchanged, despite delays in approvals for Datroway in the lung cancer field ... offset Datroway’s shortfall. Daiichi Sankyo’s Q3 FY2024 results reflect ...
A man's wife and 12-year-old daughter, who survived cancer as a baby, were among the victims in the American Airlines tragedy. In an interview with ABC News, Andy Beyer opened up about losing his ...
“Increasing access to multi-cancer early detection screenings will not only drastically improve quality of life for American cancer patients and their families while saving taxpayer ...
leading to three of the largest licensing deals in history along with the approvals of ENHERTU ® and DATROWAY ®, two precision cancer medicines invented with Daiichi Sankyo’s DXd ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results